[The modification of the effect of phenelzine, phenylpropylhydrazine and aminooxyacetic acid on the content of gamma-aminobutyric acid in the rat brain by monoamine oxidase inhibitors].
D000613:Aminobutyrates / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004336:Drug Antagonism; D005260:Female; D005998:Glycine / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008297:Male; D010624:Phenelzine / Q000494:pharmacology*; D010659:Phenylhydrazines / Q000494:pharmacology*; D011736:Pyridoxine / Q000494:pharmacology*; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology*
D000613:Aminobutyrates; D010659:Phenylhydrazines; D014191:Tranylcypromine; D011736:Pyridoxine; D010624:Phenelzine; D005998:Glycine
Die Beeinflussung der Wirkung von Phenelzin, Phenylpropylhydrazin und Aminooxyessigsäure auf den Gehalt an gamma-Aminobuttersäure des Rattenhirns durch Monoaminoxydase-Hemmstoffe.